BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 19, Issue 8
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (16208)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-2) series.
Item 
Count 
PDF2045
HTML13939
Figures (1-2)224
 Sum=16208
Feb 28, 2013 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Basaranoglu M, Basaranoglu G, Sabuncu T, Sentürk H. Fructose as a key player in the development of fatty liver disease. World J Gastroenterol 2013; 19(8): 1166-1172 [PMID: 23482247 DOI: 10.3748/wjg.v19.i8.1166]
URL: https://www.wjgnet.com/1007-9327/full/v19/i8/1166.htm
Number Citing Articles
1
Laongdao Thongnak, Varanuj Chatsudthipong, Aphisek Kongkaew, Anusorn Lungkaphin. Effects of dapagliflozin and statins attenuate renal injury and liver steatosis in high-fat/high-fructose diet-induced insulin resistant rats. Toxicology and Applied Pharmacology 2020; 396: 114997 doi: 10.1016/j.taap.2020.114997
2
Rafat A. Siddiqui, Zhidong Xu, Kevin A. Harvey, Thomas M. Pavlina, Michael J. Becker, Gary P. Zaloga. Comparative study of the modulation of fructose/sucrose-induced hepatic steatosis by mixed lipid formulations varying in unsaturated fatty acid content. Nutrition & Metabolism 2015; 12(1) doi: 10.1186/s12986-015-0038-x
3
Santiago Domínguez-Coello, Lourdes Carrillo-Fernández, Jesús Gobierno-Hernández, Manuel Méndez-Abad, Carlos Borges-Álamo, José Antonio García-Dopico, Armando Aguirre-Jaime, Antonio Cabrera-de León. Decreased Consumption of Added Fructose Reduces Waist Circumference and Blood Glucose Concentration in Patients with Overweight and Obesity. The DISFRUTE Study: A Randomised Trial in Primary Care. Nutrients 2020; 12(4): 1149 doi: 10.3390/nu12041149
4
Lei Liu, Tian Li, Yilie Liao, Yalong Wang, Yang Gao, Haikun Hu, Haipeng Huang, Fang Wu, Ye-Guang Chen, Shuhua Xu, Suneng Fu. Triose Kinase Controls the Lipogenic Potential of Fructose and Dietary Tolerance. Cell Metabolism 2020; 32(4): 605 doi: 10.1016/j.cmet.2020.07.018
5
Maya K. Shimony, Karen C. Schliep, Enrique F. Schisterman, Katherine A. Ahrens, Lindsey A. Sjaarda, Yaron Rotman, Neil J. Perkins, Anna Z. Pollack, Jean Wactawski-Wende, Sunni L. Mumford. The relationship between sugar-sweetened beverages and liver enzymes among healthy premenopausal women: a prospective cohort study. European Journal of Nutrition 2016; 55(2): 569 doi: 10.1007/s00394-015-0876-3
6
Travis R. Madaris, Manigandan Venkatesan, Soumya Maity, Miriam C. Stein, Neelanjan Vishnu, Mridula K. Venkateswaran, James G. Davis, Karthik Ramachandran, Sukanthathulse Uthayabalan, Cristel Allen, Ayodeji Osidele, Kristen Stanley, Nicholas P. Bigham, Terry M. Bakewell, Melanie Narkunan, Amy Le, Varsha Karanam, Kang Li, Aum Mhapankar, Luke Norton, Jean Ross, M. Imran Aslam, W. Brian Reeves, Brij B. Singh, Jeffrey Caplan, Justin J. Wilson, Peter B. Stathopulos, Joseph A. Baur, Muniswamy Madesh. Limiting Mrs2-dependent mitochondrial Mg2+ uptake induces metabolic programming in prolonged dietary stress. Cell Reports 2023; 42(3): 112155 doi: 10.1016/j.celrep.2023.112155
7
David E. Amacher. Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease. Biomarkers 2014; 19(7): 541 doi: 10.3109/1354750X.2014.958535
8
Cilius Esmann Fonvig, Jens-Christian Holm. The Human Gut-Liver-Axis in Health and Disease. 2019; : 47 doi: 10.1007/978-3-319-98890-0_3
9
Johanna K. DiStefano. Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis. Cellular and Molecular Life Sciences 2020; 77(11): 2079 doi: 10.1007/s00018-019-03390-0
10
Asdrubal Aguilera-Mendez, María G. Hernández-Equihua, Alfonso C. Rueda-Rocha, Clotilde Guajardo-López, Renato Nieto-Aguilar, Deyanira Serrato-Ochoa, León F. Ruíz Herrera, José A. Guzmán-Nateras. Protective effect of supplementation with biotin against high-fructose-induced metabolic syndrome in rats. Nutrition Research 2018; 57: 86 doi: 10.1016/j.nutres.2018.06.007
11
Ren Lin, Yue Jia, Fengjuan Wu, Yuan Meng, Qi Sun, Lihong Jia. Combined Exposure to Fructose and Bisphenol A Exacerbates Abnormal Lipid Metabolism in Liver of Developmental Male Rats. International Journal of Environmental Research and Public Health 2019; 16(21): 4152 doi: 10.3390/ijerph16214152
12
Maria Luisa Fiorello, Andrew T. Treweeke, David P. Macfarlane, Ian L. Megson, Jyotshna Kanungo. Intermittent exposure of cultured endothelial cells to physiologically relevant fructose concentrations has a profound impact on nitric oxide production and bioenergetics. PLOS ONE 2022; 17(5): e0267675 doi: 10.1371/journal.pone.0267675
13
Omar Ramos-Lopez, Erika Martinez-Lopez, Sonia Roman, Nora A Fierro, Arturo Panduro. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico. World Journal of Gastroenterology 2015; 21(41): 11552-11566 doi: 10.3748/wjg.v21.i41.11552
14
Gao Sun, Charles V. Jackson, Karen Zimmerman, Li-Kun Zhang, Courtney M. Finnearty, George E. Sandusky, Guodong Zhang, Richard G. Peterson, Yi-Xin (Jim) Wang. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0958-4
15
Camila Sanches Manca, Lívia Maria Cordeiro Simões-Ambrosio, Paula Payão Ovídio, Leandra Zambelli Ramalho, Alceu Afonso Jordao, Chan‐Yen Kuo. Effects of Different Vegetable Oils on the Nonalcoholic Fatty Liver Disease in C57/BL Mice. Evidence-Based Complementary and Alternative Medicine 2023; 2023(1) doi: 10.1155/2023/4197955
16
Masayoshi Takeuchi, Jun-ichi Takino, Akiko Sakasai-Sakai, Takanobu Takata, Tadashi Ueda, Mikihiro Tsutsumi, Hideyuki Hyogo, Sho-ichi Yamagishi. Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies. World Journal of Hepatology 2014; 6(12): 880-893 doi: 10.4254/wjh.v6.i12.880
17
Edyta Maslak, Elzbieta Buczek, Antoni Szumny, Wojciech Szczepnski, Magdalena Franczyk-Zarow, Aneta Kopec, Stefan Chlopicki, Teresa Leszczynska, Renata B. Kostogrys. Individual CLA Isomers, c9t11 and t10c12, Prevent Excess Liver Glycogen Storage and Inhibit Lipogenic Genes Expression Induced by High-Fructose Diet in Rats. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/535982
18
Vignan Manne, Priya Handa, Kris V. Kowdley. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2018; 22(1): 23 doi: 10.1016/j.cld.2017.08.007
19
Toshifumi Yodoshi, Ana Catalina Arce-Clachar, Qin Sun, Lin Fei, Kristin Bramlage, Stavra A. Xanthakos, Francisco Flores, Marialena Mouzaki. Glomerular Hyperfiltration Is Associated with Liver Disease Severity in Children with Nonalcoholic Fatty Liver Disease. The Journal of Pediatrics 2020; 222: 127 doi: 10.1016/j.jpeds.2020.03.038
20
Yao Chen, Lexiang Yu, Yan Wei, Yang Long, Yong Xu, Tao He, Rongqiao He. D-ribose increases triglyceride via upregulation of DGAT in the liver. Science China Life Sciences 2019; 62(6): 858 doi: 10.1007/s11427-019-9542-2
21
Johanna K. DiStefano, Glenn S. Gerhard. NAFLD in normal weight individuals. Diabetology & Metabolic Syndrome 2022; 14(1) doi: 10.1186/s13098-022-00814-z
22
Johan Wölber. Einfluss der Ernährung auf die Mundgesundheit. Zahnmedizin up2date 2020; 14(05): 379 doi: 10.1055/a-1304-0567
23
Merve Guney-Coskun, Metin Basaranoglu. Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy. World Journal of Gastroenterology 2024; 30(43): 4682-4688 doi: 10.3748/wjg.v30.i43.4682
24
Maud Rizk, Adrien Guilloteau, Thomas Mouillot, Gérard Thiefin, Jean-Pierre Bronowicki, Carine Richou, Michel Doffoel, Mona Diab Assaf, Patrick Hillon, Vanessa Cottet. Dietary components modulate the risk of hepatocellular carcinoma in cirrhotic patients. Nutrition Research 2019; 61: 82 doi: 10.1016/j.nutres.2018.10.002
25
Sri Andarini, Gati Lingga Kiwari, Dian Handayani. Magnesium-Rich Indonesian Brown Rice ‘Sintanur’ Improves Insulin Sensitivity in High Fat High Fructose Diet-Induced Obesity Sprague Dawley Rats. WSEAS TRANSACTIONS ON SYSTEMS 2022; 21: 257 doi: 10.37394/23202.2022.21.28
26
Ellen Vercalsteren, Christine Vranckx, Katrien Corbeels, Bart Van der Schueren, Greetje Vande Velde, Roger Lijnen, Ilse Scroyen. Carbohydrates to Prevent and Treat Obesity in a Murine Model of Diet-Induced Obesity. Obesity Facts 2021; 14(4): 370 doi: 10.1159/000516630
27
Renata B. Kostogrys, Magdalena Franczyk-Żarów, Edyta Maślak, Kinga Topolska. Effect of low carbohydrate high protein (LCHP) diet on lipid metabolism, liver and kidney function in rats. Environmental Toxicology and Pharmacology 2015; 39(2): 713 doi: 10.1016/j.etap.2015.01.008
28
Anil Sakamuri, Sujatha Pitla, Uday Kumar Putcha, Sugeedha Jayapal, Sailaja Pothana, Sai Santosh Vadakattu, Nagabhushan Reddy Konapalli, Siva Sankara Vara Prasad Sakamuri, Ahamed Ibrahim. Transient Decrease in Circulatory Testosterone and Homocysteine Precedes the Development of Metabolic Syndrome Features in Fructose-Fed Sprague Dawley Rats. Journal of Nutrition and Metabolism 2016; 2016: 1 doi: 10.1155/2016/7510840
29
Lakiea S. Wright, Sheryl L. Rifas-Shiman, Emily Oken, Augusto A. Litonjua, Diane R. Gold. Prenatal and Early Life Fructose, Fructose-Containing Beverages, and Midchildhood Asthma. Annals of the American Thoracic Society 2018; 15(2): 217 doi: 10.1513/AnnalsATS.201707-530OC
30
Amedeo Lonardo, Stefano Ballestri, Giulio Marchesini, Paul Angulo, Paola Loria. Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome. Digestive and Liver Disease 2015; 47(3): 181 doi: 10.1016/j.dld.2014.09.020
31
Kampeebhorn Boonloh, Ratthipha Thanaruksa, Tunvaraporn Proongkhong, Supawan Thawornchinsombut, Patchareewan Pannangpetch. Nil-Surin Rice Bran Hydrolysates Improve Lipid Metabolism and Hepatic Steatosis by Regulating Secretion of Adipokines and Expression of Lipid-Metabolism Genes. Journal of Medicinal Food 2022; 25(6): 597 doi: 10.1089/jmf.2021.K.0170
32
Natalia Vallianou, Gerasimos Socrates Christodoulatos, Irene Karampela, Dimitrios Tsilingiris, Faidon Magkos, Theodora Stratigou, Dimitris Kounatidis, Maria Dalamaga. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Biomolecules 2021; 12(1): 56 doi: 10.3390/biom12010056
33
Michael Gentzel. Obesity, Metabolic Syndrome, and Sugar-Sweetened Beverages (SSBs) in America: A Novel Bioethical Argument for a Radical Public Health Proposal. Journal of Bioethical Inquiry 2024;  doi: 10.1007/s11673-024-10369-5
34
Dijana Mirić, Bojana Kisić, Dragana Pavlović, Ilija Dragojević, Sladoje Puhalo. Fructose metabolism: The pathogenic potential of a little molecule. Praxis medica 2022; 51(3-4): 45 doi: 10.5937/pramed2204045M
35
Eliete Dalla Corte Frantz, Renata Frauches Medeiros, Isabele Gomes Giori, Juliana Bittencourt Silveira Lima, Thais Bento‐Bernardes, Thaiane Gadioli Gaique, Caroline Fernandes‐Santos, Tiago Fernandes, Edilamar Menezes Oliveira, Carla Paulo Vieira, Carlos Adam Conte‐Junior, Karen Jesus Oliveira, Antonio Claudio Lucas Nobrega. Exercise training modulates the hepatic renin–angiotensin system in fructose‐fed rats. Experimental Physiology 2017; 102(9): 1208 doi: 10.1113/EP085924
36
Konstantinos Kakleas, Foteini Christodouli, Kyriaki Karavanaki. Nonalcoholic fatty liver disease, insulin resistance, and sweeteners: a literature review. Expert Review of Endocrinology & Metabolism 2020; 15(2): 83 doi: 10.1080/17446651.2020.1740588
37
J. G. Birulina, V. V. Ivanov, E. E. Buyko, V. V. Bykov, L V. Smagliy, A. V. Nosarev, I. V. Petrova, S. V. Gusakova. High-fat, high-carbohydrate diet-induced experimental model of metabolic syndrome in rats. Bulletin of Siberian Medicine 2021; 19(4): 14 doi: 10.20538/1682-0363-2020-4-14-20
38
Nachimuthu Maithilikarpagaselvi, Magadi Gopalakrishna Sridhar, Rathinam Palamalai Swaminathan, Bobby Zachariah. Curcumin prevents inflammatory response, oxidative stress and insulin resistance in high fructose fed male Wistar rats: Potential role of serine kinases. Chemico-Biological Interactions 2016; 244: 187 doi: 10.1016/j.cbi.2015.12.012
39
David P. Nunes, Surakit Pungpapong. Complications of Cirrhosis. 2015; : 281 doi: 10.1007/978-3-319-13614-1_29
40
Charles E. Foulds, Lindsey S. Treviño, Brian York, Cheryl L. Walker. Endocrine-disrupting chemicals and fatty liver disease. Nature Reviews Endocrinology 2017; 13(8): 445 doi: 10.1038/nrendo.2017.42
41
Hee Jae Lee, Soo Jin Yang. Effects of Dietary Fructose and Glucose on Hepatic Steatosis and NLRP3 Inflammasome in a Rodent Model of Obesity and Type 2 Diabetes. Journal of the Korean Society of Food Science and Nutrition 2013; 42(10): 1576 doi: 10.3746/jkfn.2013.42.10.1576
42
John Nowicki, Joseph E. Pizzorno. Textbook of Natural Medicine. 2020; : 1600 doi: 10.1016/B978-0-323-43044-9.00200-4
43
Fang Yuan, Xu Teng, Zan Guo, Jing-Jing Zhou, Yi Zhang, Sheng Wang. Chronic intermittent hypobaric hypoxia ameliorates endoplasmic reticulum stress mediated liver damage induced by fructose in rats. Life Sciences 2015; 121: 40 doi: 10.1016/j.lfs.2014.11.019
44
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Jun Kato, Shiho Tokunaga, Taka-aki Sugihara, Yuichi Hara, Keisuke Hino, Yoshikazu Murawaki, Gonzalo Carrasco-Avino. A Series of microRNA in the Chromosome 14q32.2 Maternally Imprinted Region Related to Progression of Non-Alcoholic Fatty Liver Disease in a Mouse Model. PLOS ONE 2016; 11(5): e0154676 doi: 10.1371/journal.pone.0154676
45
Louis H. S. Lau, Sunny H. Wong. Obesity, Fatty Liver and Liver Cancer. Advances in Experimental Medicine and Biology 2018; 1061: 111 doi: 10.1007/978-981-10-8684-7_9
46
Woo-Gyun Choi, Jaeseok Han, Ji-Hyeon Kim, Mi-Jeong Kim, Jae-Woo Park, Benbo Song, Hee-Jeong Cha, Hye-Seon Choi, Hun-Taeg Chung, In-Kyu Lee, Tae-Sik Park, Maria Hatzoglou, Hueng-Sik Choi, Hyun Ju Yoo, Randal J. Kaufman, Sung Hoon Back. eIF2α phosphorylation is required to prevent hepatocyte death and liver fibrosis in mice challenged with a high fructose diet. Nutrition & Metabolism 2017; 14(1) doi: 10.1186/s12986-017-0202-6
47
Undurti N. Das. Sucrose, fructose, glucose, and their link to metabolic syndrome and cancer. Nutrition 2015; 31(1): 249 doi: 10.1016/j.nut.2014.05.015
48
Fernando Windemuller, Jiliu Xu, Simon S Rabinowitz, M Mahmood Hussain, Steven M Schwarz. Lipogenesis in Huh7 cells is promoted by increasing the fructose: Glucose molar ratio. World Journal of Hepatology 2016; 8(20): 838-843 doi: 10.4254/wjh.v8.i20.838
49
Piero Portincasa, Mohamad Khalil, Laura Mahdi, Valeria Perniola, Valeria Idone, Annarita Graziani, Gyorgy Baffy, Agostino Di Ciaula. Metabolic Dysfunction–Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options. International Journal of Molecular Sciences 2024; 25(11): 5640 doi: 10.3390/ijms25115640
50
Stephen A. Harrison, Mark M. Pence, Amy N. Stratton, Dawn M. Torres. Zakim and Boyer's Hepatology. 2018; : 406 doi: 10.1016/B978-0-323-37591-7.00027-6
51
Sanja Stojsavljević, Marija Gomerčić Palčić, Lucija Virović Jukić, Lea Smirčić Duvnjak, Marko Duvnjak. Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2014; 20(48): 18070-18091 doi: 10.3748/wjg.v20.i48.18070
52
Carolina Gabriela Plazas Guerrero, Selene De Jesús Acosta Cota, Francisco Humberto Castro Sánchez, Marcela De Jesús Vergara Jiménez, Efrén Rafael Ríos Burgueño, Juan Ignacio Sarmiento Sánchez, Lorenzo Antonio Picos Corrales, Ulises Osuna Martínez. Evaluation of sucrose-enriched diet consumption in the development of risk factors associated to type 2 diabetes, atherosclerosis and non-alcoholic fatty liver disease in a murine model. International Journal of Environmental Health Research 2021; 31(6): 651 doi: 10.1080/09603123.2019.1680817
53
Metin Basaranoglu. Increased prevalence of portal vein thrombosis in patients with nonalcoholic steatohepatitis-cirrhosis due to increased proinflammatory cytokines releasing from abdominal adipose tissue. European Journal of Gastroenterology & Hepatology 2020; 32(3): 458 doi: 10.1097/MEG.0000000000001564
54
Charlotte J. Green, Camilla Pramfalk, Karl J. Morten, Leanne Hodson. From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations. American Journal of Physiology-Endocrinology and Metabolism 2015; 308(1): E1 doi: 10.1152/ajpendo.00192.2014
55
Christopher Chronowski, Viktor Akhanov, Doug Chan, Andre Catic, Milton Finegold, Ergün Sahin. Fructose Causes Liver Damage, Polyploidy, and Dysplasia in the Setting of Short Telomeres and p53 Loss. Metabolites 2021; 11(6): 394 doi: 10.3390/metabo11060394
56
Seung Jin Han, Sung-E Choi, Sang-A Yi, Jong Gab Jung, Ik-Rak Jung, Maureen Shin, Seok Kang, Hyunhee Oh, Hae Jin Kim, Dae Jung Kim, Ji Eun Kwon, Cheol Soo Choi, Kwan Woo Lee, Yup Kang. Glutamate dehydrogenase activator BCH stimulating reductive amination prevents high fat/high fructose diet-induced steatohepatitis and hyperglycemia in C57BL/6J mice. Scientific Reports 2016; 6(1) doi: 10.1038/srep37468
57
Maria Notarnicola, Alberto Ruben Osella, Maria Gabriella Caruso, Pasqua Letizia Pesole, Antonio Lippolis, Valeria Tutino, Caterina Bonfiglio, Valentina De Nunzio, Maria Principia Scavo, Antonella Mirizzi, Isabella Franco, Tamara Lippolis, Rosalba D’Alessandro, Maria Grazia Refolo, Caterina Messa. Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions. International Journal of Molecular Sciences 2021; 22(8): 3899 doi: 10.3390/ijms22083899
58
Yong-Song Guan, Qing He. A Current Update on the Rule of Alternative and Complementary Medicine in the Treatment of Liver Diseases. Evidence-Based Complementary and Alternative Medicine 2013; 2013: 1 doi: 10.1155/2013/321234
59
Roger A. Clemens, Julie M. Jones, Mark Kern, Soo‐Yeun Lee, Emily J. Mayhew, Joanne L. Slavin, Svetlana Zivanovic. Functionality of Sugars in Foods and Health. Comprehensive Reviews in Food Science and Food Safety 2016; 15(3): 433 doi: 10.1111/1541-4337.12194
60
Metin Basaranoglu, Alev Kurtoglu. Replacing the Name of NAFLD With a Metabolic or Another Forename as Indicator of the Era of Stagnation in NASH Studies. Journal of Clinical Gastroenterology 2021; 55(6): 548 doi: 10.1097/MCG.0000000000001494
61
Erin Vanessa LaRae Smith, Rebecca Maree Dyson, Freya Rebecca Weth, Mary Judith Berry, Clint Gray. Maternal Fructose Intake, Programmed Mitochondrial Function and Predisposition to Adult Disease. International Journal of Molecular Sciences 2022; 23(20): 12215 doi: 10.3390/ijms232012215
62
Manoela Mota, Bubu A. Banini, Sophie C. Cazanave, Arun J. Sanyal. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease. Metabolism 2016; 65(8): 1049 doi: 10.1016/j.metabol.2016.02.014
63
Akiko Sakasai-Sakai, Takanobu Takata, Jun-ichi Takino, Masayoshi Takeuchi. The Relevance of Toxic AGEs (TAGE) Cytotoxicity to NASH Pathogenesis: A Mini-Review. Nutrients 2019; 11(2): 462 doi: 10.3390/nu11020462
64
Genaro Matus-Ortega, Lucero Romero-Aguilar, James González, Guadalupe Guerra Sánchez, Maura Matus-Ortega, Víctor Del Castillo-Falconi, Juan Pablo Pardo. El ciclo de Randle, el precario vínculo entre azúcares y grasas. TIP Revista Especializada en Ciencias Químico-Biológicas 2020; 23 doi: 10.22201/fesz.23958723e.2020.0.270
65
Sebastian J. Neggers, Aart J. van der Lely. Thyroid Diseases. Endocrinology 2018; : 1 doi: 10.1007/978-3-319-38681-2_17-1
66
Sebastian J. Neggers, Aart J. van der Lely. Hypothalamic-Pituitary Diseases. Endocrinology 2018; : 497 doi: 10.1007/978-3-319-44444-4_17
67
Emer Fitzpatrick. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. 2022; : 911 doi: 10.1007/978-3-030-80068-0_69
68
Simona Marchisello, Antonino Di Pino, Roberto Scicali, Francesca Urbano, Salvatore Piro, Francesco Purrello, Agata Rabuazzo. Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview. International Journal of Molecular Sciences 2019; 20(8): 1948 doi: 10.3390/ijms20081948
69
John K. Meissen, Kristin M. Hirahatake, Sean H. Adams, Oliver Fiehn. Temporal metabolomic responses of cultured HepG2 liver cells to high fructose and high glucose exposures. Metabolomics 2015; 11(3): 707 doi: 10.1007/s11306-014-0729-8
70
M.J. Goss, M.L.O. Nunes, I.D. Machado, L. Merlin, N.B. Macedo, A.M.O. Silva, T.M.B. Bresolin, J.R. Santin. Peel flour of Passiflora edulis Var. Flavicarpa supplementation prevents the insulin resistance and hepatic steatosis induced by low-fructose-diet in young rats. Biomedicine & Pharmacotherapy 2018; 102: 848 doi: 10.1016/j.biopha.2018.03.137
71
M. Kouvari, C. Boutari, C. Chrysohoou, E. Fragkopoulou, S. Antonopoulou, D. Tousoulis, C. Pitsavos, D.B. Panagiotakos, C.S. Mantzoros. Mediterranean diet is inversely associated with steatosis and fibrosis and decreases ten-year diabetes and cardiovascular risk in NAFLD subjects: Results from the ATTICA prospective cohort study. Clinical Nutrition 2021; 40(5): 3314 doi: 10.1016/j.clnu.2020.10.058
72
Leandro Kansuke OHAROMARI, Mateus Luís MANFREDI, Anderson Gregório JOAQUIM, Patricia CHIMIN, Camila DE MORAES. Continuous or interval aerobic exercise training reduces daily fructose intake in female Wistar rat. Revista de Nutrição 2022; 35 doi: 10.1590/1678-9865202235e220052
73
Rebecca C Mollard, Martin Sénéchal, Andrea C MacIntosh, Jacqueline Hay, Brandy A Wicklow, Kristy DM Wittmeier, Elizabeth AC Sellers, Heather J Dean, Lawrence Ryner, Lori Berard, Jonathan M McGavock. Dietary determinants of hepatic steatosis and visceral adiposity in overweight and obese youth at risk of type 2 diabetes. The American Journal of Clinical Nutrition 2014; 99(4): 804 doi: 10.3945/ajcn.113.079277
74
Prasanthi Jegatheesan, Stéphanie Beutheu, Gabrielle Ventura, Gilles Sarfati, Esther Nubret, Nathalie Kapel, Anne-Judith Waligora-Dupriet, Ina Bergheim, Luc Cynober, Jean-Pascal De-Bandt. Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease. Clinical Nutrition 2016; 35(1): 175 doi: 10.1016/j.clnu.2015.01.021
75
Takayuki Ozawa, Natsumi Maehara, Toshihiro Kai, Satoko Arai, Toru Miyazaki. Dietary fructose‐induced hepatocellular carcinoma development manifested in mice lacking apoptosis inhibitor of macrophage (AIM). Genes to Cells 2016; 21(12): 1320 doi: 10.1111/gtc.12446
76
Wenfeng Li, Hongyan Yang, Qiang Zhao, Xv Wang, Jing Zhang, Xin Zhao. Polyphenol-Rich Loquat Fruit Extract Prevents Fructose-Induced Nonalcoholic Fatty Liver Disease by Modulating Glycometabolism, Lipometabolism, Oxidative Stress, Inflammation, Intestinal Barrier, and Gut Microbiota in Mice. Journal of Agricultural and Food Chemistry 2019; 67(27): 7726 doi: 10.1021/acs.jafc.9b02523
77
Sara Della Torre. Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.572490
78
Jake B. Hermanson, Samar A. Tolba, Evan A. Chrisler, Vanessa A. Leone. Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine. The Journal of Nutritional Biochemistry 2024; 133: 109704 doi: 10.1016/j.jnutbio.2024.109704
79
A.F. Sheptulina, J.A. Golubeva, O.M. Drapkina. Fructose consumption as a risk factor for metabolic syndrome and nonalcoholic fatty liver disease. Dokazatel'naya gastroenterologiya 2023; 12(1): 85 doi: 10.17116/dokgastro20231201185
80
Metin Demirel, Fatmanur Köktaşoğlu, Esin Özkan, Halime Dulun Ağaç, Ayşe Zehra Gül, Rasul Sharifov, Ufuk Sarıkaya, Metin Başaranoğlu, Şahabettin Selek. Mass spectrometry-based untargeted metabolomics study of non-obese individuals with non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 2023; 58(11): 1344 doi: 10.1080/00365521.2023.2225667
81
M M S Engel, I Kusumastuty, K W Anita, D Handayani. The Effect of High Fat High Fructose Diet (Modification of AIN-93M) on Nuclear Factor Kappa Beta Expression in the Liver Tissue of Male Sprague Dawley Rats. Journal of Physics: Conference Series 2019; 1374(1): 012042 doi: 10.1088/1742-6596/1374/1/012042
82
Shazia F. Bhat, Sara E. Pinney, Katherine M. Kennedy, Cole R. McCourt, Miles A. Mundy, Michael G. Surette, Deborah M. Sloboda, Rebecca A. Simmons. Exposure to high fructose corn syrup during adolescence in the mouse alters hepatic metabolism and the microbiome in a sex‐specific manner. The Journal of Physiology 2021; 599(5): 1487 doi: 10.1113/JP280034
83
Nontobeko M. Gumede, Busisani W. Lembede, Pilani Nkomozepi, Richard L. Brooksbank, Kennedy H. Erlwanger, Eliton Chivandi. β-Sitosterol mitigates the development of high-fructose diet-induced nonalcoholic fatty liver disease in growing male Sprague–Dawley rats. Canadian Journal of Physiology and Pharmacology 2020; 98(1): 44 doi: 10.1139/cjpp-2019-0295
84
Pooja Yadav, Khushi Quadri, Renu Kadian, Aafrin Waziri, Pankaj Agrawal, Md Sabir Alam. New Approaches to the Treatment of Metabolic Dysfunction-Associated Steatotic Liver with Natural Products. iLIVER 2024; : 100131 doi: 10.1016/j.iliver.2024.100131
85
Metin Basaranoglu. Lean and Nonobese NAFLD/NASH From a Hepatologist’s Point of View. Journal of Clinical Gastroenterology 2021; 55(1): 93 doi: 10.1097/MCG.0000000000001428
86
Martijn R. Molenaar, Louis C. Penning, J. Bernd Helms. Playing Jekyll and Hyde—The Dual Role of Lipids in Fatty Liver Disease. Cells 2020; 9(10): 2244 doi: 10.3390/cells9102244
87
Charlotte Green, Leanne Hodson. The Influence of Dietary Fat on Liver Fat Accumulation. Nutrients 2014; 6(11): 5018 doi: 10.3390/nu6115018
88
Nathan Denton. Waisted: The Biology of Body Fat. 2021; : 197 doi: 10.1093/med/9780198865278.003.0007
89
Prerna Sahu, Pratyaksh Chhabra, Ashok M Mehendale. A Comprehensive Review on Non-Alcoholic Fatty Liver Disease. Cureus 2023;  doi: 10.7759/cureus.50159
90
Jacques Delarue, Jean-Paul Lallès. Rôles de l’intestin et du foie dans la progression de la stéatopathie métabolique et sa modulation par les acides gras polyinsaturés à longue chaîne n-3. Cahiers de Nutrition et de Diététique 2016; 51(6): 283 doi: 10.1016/j.cnd.2016.09.002
91
Farkhondeh Alami, Mohammad Alizadeh, Kamran Shateri. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial. Scandinavian Journal of Gastroenterology 2022; 57(10): 1238 doi: 10.1080/00365521.2022.2071109
92
Mirosław Krośniak, Renata Francik, Agnieszka Wojtanowska-Krośniak, Cinzia Tedeschi, Małgorzata Krasoń-Nowak, Joanna Chłopicka, Ryszard Gryboś. Vanadium Methyl-Bipyridine Organoligand and its Influence on Energy Balance and Organs Mass. Biological Trace Element Research 2014; 160(3): 376 doi: 10.1007/s12011-014-0064-y
93
Allan Stubbe Christensen, Lone Viggers, Søren Gregersen. Glucose Intake and Utilization in Pre-Diabetes and Diabetes. 2015; : 215 doi: 10.1016/B978-0-12-800093-9.00017-X
94
Jinying Zheng, Chuan Peng, Yanbiao Ai, Heng Wang, Xiaoqiu Xiao, Jibin Li. Docosahexaenoic Acid Ameliorates Fructose-Induced Hepatic Steatosis Involving ER Stress Response in Primary Mouse Hepatocytes. Nutrients 2016; 8(1): 55 doi: 10.3390/nu8010055
95
Maryam Afsharfar, Zahra Salimi, Bahareh Aminnezhad kavkani, Soheila Shekari, Saheb Abbastorki, Nazanin Majidi, Maryam Gholamalizadeh, Alireza Mosavi Jarrahi, Azadeh Hajipour, Hanieh Shafaei, Saeid Doaei. Association of nonalcoholic fatty liver disease with the different types of dietary carbohydrates: a cross-sectional study. Journal of Diabetes & Metabolic Disorders 2023; 22(2): 1139 doi: 10.1007/s40200-023-01223-3
96
Metin Basaranoglu, Sonia M Najjar, Ali Ebag Demirbag, Hakan Senturk. Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list. World Journal of Hepatology 2016; 8(7): 376-384 doi: 10.4254/wjh.v8.i7.376
97
Amani Elshaer, David M. H. Chascsa, Blanca C. Lizaola-Mayo. Exploring Varied Treatment Strategies for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Life 2024; 14(7): 844 doi: 10.3390/life14070844
98
S. V. Ivanov, R. U. Ostrovskaya. Combination of a high-carbohydrate diet and streptozotoc in for modeling type 2 diabetes in Wistar rats. Pharmacokinetics and Pharmacodynamics 2023; (2): 54 doi: 10.37489/2587-7836-2023-2-54-59
99
Yuling Chi, Dou Yeon Youn, Alus M. Xiaoli, Li Liu, Yunping Qiu, Irwin J. Kurland, Jacob B. Pessin, Fajun Yang, Jeffrey E. Pessin. Comparative impact of dietary carbohydrates on the liver transcriptome in two strains of mice. Physiological Genomics 2021; 53(11): 456 doi: 10.1152/physiolgenomics.00053.2021
100
Mark C.C. Cheah, Arthur J. McCullough, George B.B. Goh. Bioactive Food as Dietary Interventions for Diabetes. 2019; : 69 doi: 10.1016/B978-0-12-813822-9.00005-9
101
Prem Prakash, Vishal Singh, Manish Jain, Minakshi Rana, Vivek Khanna, Manoj Kumar Barthwal, Madhu Dikshit. Silymarin ameliorates fructose induced insulin resistance syndrome by reducing de novo hepatic lipogenesis in the rat. European Journal of Pharmacology 2014; 727: 15 doi: 10.1016/j.ejphar.2014.01.038
102
Yanzhong Liu, Dan Wang, Yi-Ping Liu. Metabolite profiles of diabetes mellitus and response to intervention in anti-hyperglycemic drugs. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1237934
103
Francis W. B. Sanders, Julian L. Griffin. De novolipogenesis in the liver in health and disease: more than just a shunting yard for glucose. Biological Reviews 2016; 91(2): 452 doi: 10.1111/brv.12178
104
Lisette Chávez-Rodríguez, Alejandro Escobedo-Calvario, Soraya Salas-Silva, Roxana U. Miranda-Labra, Leticia Bucio, Verónica Souza, María Concepción Gutiérrez-Ruiz, Luis E. Gomez-Quiroz. Fructose Consumption and Hepatocellular Carcinoma Promotion. Livers 2021; 1(4): 250 doi: 10.3390/livers1040020
105
Yijun Lin, Hong Ye, Yan Chen, Rui Zhang, Yuyun Chen, Weijie Ou. Integrative Analyses of Genes of Pediatric Non-alcoholic Fatty Liver Disease Associated with Energy Metabolism. Digestive Diseases and Sciences 2024;  doi: 10.1007/s10620-024-08702-4
106
Feryal Savari, Seyyed Ali Mard, Mohammad Badavi, Anahita Rezaie, Mohammad Kazem Gharib-Naseri. A new method to induce nonalcoholic steatohepatitis (NASH) in mice. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1041-x
107
Richard Todd Handley, Ryan E Bentley, Tony L Brown, Abigail A Annan. Successful treatment of obesity and insulin resistance via ketogenic diet status post Roux-en-Y. BMJ Case Reports 2018; : bcr-2018-225643 doi: 10.1136/bcr-2018-225643
108
Emer Fitzpatrick. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. 2016; : 753 doi: 10.1007/978-3-319-17169-2_66
109
Samar G. Mohammed, Islam A.A.E.-H. Ibrahim, Mona F. Mahmoud, Amr A.A. Mahmoud. Carvedilol protects against hepatic ischemia/reperfusion injury in high-fructose/high-fat diet-fed mice: Role of G protein-coupled receptor kinase 2 and 5. Toxicology and Applied Pharmacology 2019; 382: 114750 doi: 10.1016/j.taap.2019.114750
110
Laia Bertran, Laia Adalid, Mercè Vilaró-Blay, Andrea Barrientos-Riosalido, Carmen Aguilar, Salomé Martínez, Fàtima Sabench, Daniel del Castillo, José Antonio Porras, Ajla Alibalic, Cristóbal Richart, Teresa Auguet. Expression of STING in Women with Morbid Obesity and Nonalcoholic Fatty Liver Disease. Metabolites 2023; 13(4): 496 doi: 10.3390/metabo13040496
111
Youying Zhang, Tian Meng, Ling Zuo, Yu Bei, Qihao Zhang, Zhijian Su, Yadong Huang, Jiyan Pang, Qi Xiang, Hongtu Yang. Xyloketal B Attenuates Fatty Acid-Induced Lipid Accumulation via the SREBP-1c Pathway in NAFLD Models. Marine Drugs 2017; 15(6): 163 doi: 10.3390/md15060163
112
Yongyan Song, Miaoyun Zhao, Xiao Cheng, Jing Shen, Rituraj Khound, Kezhong Zhang, Qiaozhu Su. CREBH mediates metabolic inflammation to hepatic VLDL overproduction and hyperlipoproteinemia. Journal of Molecular Medicine 2017; 95(8): 839 doi: 10.1007/s00109-017-1534-4
113
Selene de Jesús Acosta-Cota, Elsa Maribel Aguilar-Medina, Rosalio Ramos-Payán, Ana Karen Ruiz-Quiñónez, José Geovanni Romero-Quintana, Julio Montes-Avila, José Guadalupe Rendón-Maldonado, Araceli Sánchez-López, David Centurión, Ulises Osuna-Martínez. Histopathological and biochemical changes in the development of nonalcoholic fatty liver disease induced by high-sucrose diet at different times. Canadian Journal of Physiology and Pharmacology 2019; 97(1): 23 doi: 10.1139/cjpp-2018-0353
114
Israel Oluwasegun Ayenigbara. The Accumulation of Visceral Fat and Preventive Measures among the Elderly. Cardiovascular Innovations and Applications 2020; 4(4) doi: 10.15212/CVIA.2019.0573
115
Laia Vilà, Ivet Elias, Carles Roca, Albert Ribera, Tura Ferré, Alba Casellas, Ricardo Lage, Sylvie Franckhauser, Fatima Bosch. AAV8-mediated Sirt1 gene transfer to the liver prevents high carbohydrate diet-induced nonalcoholic fatty liver disease. Molecular Therapy - Methods & Clinical Development 2014; 1: 14039 doi: 10.1038/mtm.2014.39
116
Johan Wölber. Einfluss der Ernährung auf die Mundgesundheit. Informationen aus Orthodontie & Kieferorthopädie 2021; 53(03): 219 doi: 10.1055/a-1553-9612
117
Seung Tae Im, Haeun Mun, Subin Park, Hyeon Kang, Wook Chul Kim, Soo-Jin Heo, Seung-Hong Lee. Ishige okamurae Celluclast extract ameliorates non-alcoholic fatty liver in high-fructose diet-fed mice by modulation of lipid metabolism and gut microbiota composition. Food and Chemical Toxicology 2023; 177: 113864 doi: 10.1016/j.fct.2023.113864
118
Ling Li, Bo Fang, Yinglei Zhang, Liuqing Yan, Yuxin He, Linfeng Hu, Qifei Xu, Qiang Li, Xianling Dai, Qin Kuang, Minxuan Xu, Jun Tan, Chenxu Ge. Carminic acid mitigates fructose-triggered hepatic steatosis by inhibition of oxidative stress and inflammatory reaction. Biomedicine & Pharmacotherapy 2022; 145: 112404 doi: 10.1016/j.biopha.2021.112404
119
Chiara DI RENZO, Alessandro VITALE, Francesco D’AMICO, Umberto CILLO. NAFLD: a multi-faceted morbid spectrum with uncertain diagnosis and complicated management. Minerva Surgery 2021; 76(5) doi: 10.23736/S2724-5691.21.08729-0
120
Nataly Shulga, John G. Pastorino. Mitoneet mediates TNFα induced necroptosis promoted by fructose and ethanol exposure. Journal of Cell Science 2013;  doi: 10.1242/jcs.140764
121
Natalia Garay-Lugo, Aarón Domínguez-Lopez, Angel Miliar García, Eliud Aguilar Barrera, Modesto Gómez López, Alejandro Gómez Alcalá, Maria de los Angeles Martínez Godinez, Eleazar Lara-Padilla. n-3 Fatty acids modulate the mRNA expression of theNlrp3inflammasome andMtorin the liver of rats fed with high-fat or high-fat/fructose diets. Immunopharmacology and Immunotoxicology 2016; 38(5): 353 doi: 10.1080/08923973.2016.1208221
122
Jie Zhou, Chi-Tang Ho, Piaopiao Long, Qilu Meng, Liang Zhang, Xiaochun Wan. Preventive Efficiency of Green Tea and Its Components on Nonalcoholic Fatty Liver Disease. Journal of Agricultural and Food Chemistry 2019; 67(19): 5306 doi: 10.1021/acs.jafc.8b05032
123
Kinya Okamoto, Masahiko Koda, Toshiaki Okamoto, Takumi Onoyama, Kenichi Miyoshi, Manabu Kishina, Tomomitsu Matono, Jun Kato, Shiho Tokunaga, Takaaki Sugihara, Akira Hiramatsu, Hideyuki Hyogo, Hiroshi Tobita, Shuichi Sato, Miwa Kawanaka, Yuichi Hara, Keisuke Hino, Kazuaki Chayama, Yoshikazu Murawaki, Hajime Isomoto, Catherine Mounier. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease. PLOS ONE 2020; 15(2): e0219412 doi: 10.1371/journal.pone.0219412
124
Komal Sodhi, Nitin Puri, Gaia Favero, Sarah Stevens, Charles Meadows, Nader G. Abraham, Rita Rezzani, Hayden Ansinelli, Edward Lebovics, Joseph I. Shapiro, Hervé Guillou. Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet. PLOS ONE 2015; 10(6): e0128648 doi: 10.1371/journal.pone.0128648
125
Daniele Pastori, Francesco Baratta, Ilaria Ernesti, Francesco Violi, Francesco Angelico, Maria Del Ben. Response to Duret et al.. American Journal of Gastroenterology 2018; 113(5): 775 doi: 10.1038/s41395-018-0055-2
126
Catherine A. Powell, Mahua Choudhury. Advancing metabolism research to overcome low litter survival in metabolically stressed mice. American Journal of Physiology-Endocrinology and Metabolism 2019; 317(2): E261 doi: 10.1152/ajpendo.00024.2019
127
Taotao Wei, Yali Dang, Jinxuan Cao, Zhen Wu, Jun He, Yangying Sun, Daodong Pan, Zhenwen Tian. Different duck products protein on rat physiology and gut microbiota. Journal of Proteomics 2019; 206: 103436 doi: 10.1016/j.jprot.2019.103436
128
Meysam Ramezani, Mahsa Zobeiry, Shahrokh Abdolahi, Behzad Hatami, Mohammad Reza Zali, Kaveh Baghaei. A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression. Pathology - Research and Practice 2023; 251: 154809 doi: 10.1016/j.prp.2023.154809
129
Eira E. Huerta-Ávila, Ivonne Ramírez-Silva, Luisa E. Torres-Sánchez, Cinthya E. Díaz-Benítez, Yaneth C. Orbe-Orihuela, Alfredo Lagunas-Martínez, Marcia Galván-Portillo, Mario Flores, Miguel Cruz, Ana I. Burguete-García. High Relative Abundance of Lactobacillus reuteri and Fructose Intake are Associated with Adiposity and Cardiometabolic Risk Factors in Children from Mexico City. Nutrients 2019; 11(6): 1207 doi: 10.3390/nu11061207
130
John Chukudi Anionye, Rawlings Osakpolor Otasowie. EFFECT OF PAXHERBAL BITTERS ON INFLAMMATION AND ANTIOXIDANT STATUS IN MALE WISTAR RATS FED A HIGH FRUCTOSE DIET. FUDMA JOURNAL OF SCIENCES 2024; 8(3): 256 doi: 10.33003/fjs-2024-0803-2358
131
Yuan-Ye Qiu, Jing Zhang, Fan-Yi Zeng, Yi Zhun Zhu. Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Pharmacological Research 2023; 192: 106786 doi: 10.1016/j.phrs.2023.106786
132
Heitor O. Santos, Nilson Penha-Silva. Revisiting the concepts of de novo lipogenesis to understand the conversion of carbohydrates into fats: Stop overvaluing and extrapolating the renowned phrase “fat burns in the flame of carbohydrate”. Nutrition 2025; 130: 112617 doi: 10.1016/j.nut.2024.112617
133
Patrizia Gena, Maria Mastrodonato, Piero Portincasa, Elena Fanelli, Donatella Mentino, Amaia Rodríguez, Raúl A. Marinelli, Catherine Brenner, Gema Frühbeck, Maria Svelto, Giuseppe Calamita, Michael Müller. Liver Glycerol Permeability and Aquaporin-9 Are Dysregulated in a Murine Model of Non-Alcoholic Fatty Liver Disease. PLoS ONE 2013; 8(10): e78139 doi: 10.1371/journal.pone.0078139
134
Jesse D. Riordan, Joseph H. Nadeau. Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse. Mammalian Genome 2014; 25(9-10): 473 doi: 10.1007/s00335-014-9521-3
135
Maki Morinaga, Kazuyoshi Kon, Hiroaki Saito, Kumiko Arai, Hiromi Kusama, Akira Uchiyama, Shunhei Yamashina, Kenichi Ikejima, Sumio Watanabe. Sodium 4-phenylbutyrate prevents murine dietary steatohepatitis caused by <i>trans</i>-fatty acid plus fructose. Journal of Clinical Biochemistry and Nutrition 2015; 57(3): 183 doi: 10.3164/jcbn.15-75
136
Masayoshi Takeuchi, Jun-ichi Takino, Akiko Sakasai-Sakai, Takanobu Takata, Mikihiro Tsutsumi. Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD. Nutrients 2017; 9(6): 634 doi: 10.3390/nu9060634
137
Elena Grasselli, Laura Canesi, Piero Portincasa, Adriana Voci, Laura Vergani, Ilaria Demori. Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine. Annals of Hepatology 2017; 16(5): 707 doi: 10.5604/01.3001.0010.2713
138
Jessie Rice, Ujjwal Ramtekkar. Integrative Management of Metabolic Syndrome in Youth Prescribed Second-Generation Antipsychotics. Medical Sciences 2020; 8(3): 34 doi: 10.3390/medsci8030034
139
Sonia M. Najjar, Lucia Russo. CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). Seminars in Immunopathology 2014; 36(1): 55 doi: 10.1007/s00281-013-0407-3
140
Jacques Delarue, Jean‐Paul Lallès. Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long‐chain n‐3 PUFA. Molecular Nutrition & Food Research 2016; 60(1): 147 doi: 10.1002/mnfr.201500346
141
Marta G. Novelle, Susana Belén Bravo, Maxime Deshons, Cristina Iglesias, María García-Vence, Rebecca Annells, Natália da Silva Lima, Rubén Nogueiras, Manuel Alejandro Fernández-Rojo, Carlos Diéguez, Amparo Romero-Picó. Impact of liver-specific GLUT8 silencing on fructose-induced inflammation and omega oxidation. iScience 2021; 24(2): 102071 doi: 10.1016/j.isci.2021.102071
142
Layla Mendonça Lírio, Ludimila Forechi, Tadeu Caliman Zanardo, Hiago Martins Batista, Eduardo Frizera Meira, Breno Valentim Nogueira, José Geraldo Mill, Marcelo Perim Baldo. Chronic fructose intake accelerates non-alcoholic fatty liver disease in the presence of essential hypertension. Journal of Diabetes and its Complications 2016; 30(1): 85 doi: 10.1016/j.jdiacomp.2015.10.008
143
Quan Zhao, Linhai Li, Yu Zhu, Dezhi Hou, Yuejin Li, Xiaodong Guo, Yongzhi Wang, Opeyemi Joshua Olatunji, Ping Wan, Kunmei Gong. <p>Kukoamine B Ameliorate Insulin Resistance, Oxidative Stress, Inflammation and Other Metabolic Abnormalities in High-Fat/High-Fructose-Fed Rats</p>. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2020; : 1843 doi: 10.2147/DMSO.S247844
144
Fatima Kasbi-Chadli, Véronique Ferchaud-Roucher, Michel Krempf, Khadija Ouguerram. Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet. European Journal of Nutrition 2016; 55(2): 589 doi: 10.1007/s00394-015-0879-0
145
Janet L. Black. Integrative and Functional Medical Nutrition Therapy. 2020; : 205 doi: 10.1007/978-3-030-30730-1_14
146
Joshua S. Wooten, Tayler N. Nick, Andrew Seija, Kaylee E. Poole, Kelsey B. Stout. High-Fructose Intake Impairs the Hepatic Hypolipidemic Effects of a High-Fat Fish-Oil Diet in C57BL/6 Mice. Journal of Clinical and Experimental Hepatology 2016; 6(4): 265 doi: 10.1016/j.jceh.2016.09.001
147
Rodrigo Pereira, José Botezelli, Kellen Da Cruz Rodrigues, Rania Mekary, Dennys Cintra, José Pauli, Adelino Da Silva, Eduardo Ropelle, Leandro De Moura. Fructose Consumption in the Development of Obesity and the Effects of Different Protocols of Physical Exercise on the Hepatic Metabolism. Nutrients 2017; 9(4): 405 doi: 10.3390/nu9040405
148
Mazen Noureddin, David Alexanian, Neil Kaplowitz. Lipid Management. 2015; : 149 doi: 10.1007/978-3-319-11161-2_9
149
A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE. PLOS ONE 2019; 14(5): e0216736 doi: 10.1371/journal.pone.0216736
150
Seon-A Jang, SungRyul Lee, Eun-Hwa Sohn, Jaehyuk Yang, Dae Won Park, Yong Joon Jeong, Inhye Kim, Jung Eun Kwon, Hae Seong Song, Young Mi Cho, Xue Meng, Hyun Jung Koo, Se Chan Kang. Cynanchum wilfordii Radix attenuates liver fat accumulation and damage by suppressing hepatic cyclooxygenase-2 and mitogen-activated protein kinase in mice fed with a high-fat and high-fructose diet. Nutrition Research 2016; 36(9): 914 doi: 10.1016/j.nutres.2016.06.007
151
Cara Mack, Shikha S. Sundaram. Pediatric Gastrointestinal and Liver Disease. 2021; : 804 doi: 10.1016/B978-0-323-67293-1.00073-6
152
Marie Hennebelle, Maggie Roy, Valérie St-Pierre, Alexandre Courchesne-Loyer, Mélanie Fortier, Anne-Karine Bouzier-Sore, Jean-Louis Gallis, Marie-Christine Beauvieux, Stephen C. Cunnane. Energy restriction does not prevent insulin resistance but does prevent liver steatosis in aging rats on a Western-style diet. Nutrition 2015; 31(3): 523 doi: 10.1016/j.nut.2014.09.009
153
Roxane St-Amand, Émilienne T. Ngo Sock, Samantha Quinn, Jean-Marc Lavoie, David H. St-Pierre. Two weeks of western diet disrupts liver molecular markers of cholesterol metabolism in rats. Lipids in Health and Disease 2020; 19(1) doi: 10.1186/s12944-020-01351-2
154
Mohammed Eslam, Naim Alkhouri, Pietro Vajro, Ulrich Baumann, Ram Weiss, Piotr Socha, Claude Marcus, Way Seah Lee, Deirdre Kelly, Gilda Porta, Mohamed A El-Guindi, Anna Alisi, Jake P Mann, Nezha Mouane, Louise A Baur, Anil Dhawan, Jacob George. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. The Lancet Gastroenterology & Hepatology 2021; 6(10): 864 doi: 10.1016/S2468-1253(21)00183-7
155
Sara Della Torre. Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology. Cells 2021; 10(9): 2502 doi: 10.3390/cells10092502
156
Bridget Young. Variation in Infant Formula Macronutrient Ingredients Is Associated with Infant Anthropometrics. Nutrients 2020; 12(11): 3465 doi: 10.3390/nu12113465
157
Joanna Maria Pieczyńska, Ewa Pruszyńska-Oszmałek, Paweł Antoni Kołodziejski, Anna Łukomska, Joanna Bajerska. The Role of a High-Fat, High-Fructose Diet on Letrozole-Induced Polycystic Ovarian Syndrome in Prepubertal Mice. Nutrients 2022; 14(12): 2478 doi: 10.3390/nu14122478
158
Ran Jin, Jean Welsh, Ngoc-Anh Le, Jeffrey Holzberg, Puneet Sharma, Diego Martin, Miriam Vos. Dietary Fructose Reduction Improves Markers of Cardiovascular Disease Risk in Hispanic-American Adolescents with NAFLD. Nutrients 2014; 6(8): 3187 doi: 10.3390/nu6083187
159
Eunjin Lim, Ji Lim, Eunju Kim, Yoo-Sun Kim, Jae-Ho Shin, Pu Seok, Sangwon Jung, Sang-Ho Yoo, Yuri Kim. Xylobiose, an Alternative Sweetener, Ameliorates Diabetes-Related Metabolic Changes by Regulating Hepatic Lipogenesis and miR-122a/33a in db/db Mice. Nutrients 2016; 8(12): 791 doi: 10.3390/nu8120791
160
Michael W Gleeson, Rolland C Dickson. Quelling Inflammation with Ketosis and Steric Chemistry. Clinical and Translational Gastroenterology 2016; 7(2): e145 doi: 10.1038/ctg.2016.6
161
In-Jin Cho, Da-Hee Oh, Jin Yoo, You-Cheol Hwang, Kyu Jeung Ahn, Ho-Yeon Chung, Soung Won Jeong, Ju-Young Moon, Sang-Ho Lee, Sung-Jig Lim, In-Kyung Jeong. Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88872-7
162
Caixia Li, Ping Li, Yee Min Tan, Siew Hong Lam, Eric C. Y. Chan, Zhiyuan Gong, Zhan Yin. Metabolomic Characterizations of Liver Injury Caused by Acute Arsenic Toxicity in Zebrafish. PLOS ONE 2016; 11(3): e0151225 doi: 10.1371/journal.pone.0151225
163
Camila Liyoko Suehiro, Alessandra Choqueta de Toledo-Arruda, Rodolfo de Paula Vieira, Francine Maria de Almeida, Clarice Rosa Olivo, Milton de Arruda Martins, Chin Jia Lin. A possible association between fructose consumption and pulmonary emphysema. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-45594-1
164
Matina Kouvari, Domenico Sergi, Manja Zec, Nenad Naumovski. Editorial: Nutrition in prevention and management of non-alcoholic fatty liver disease. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1212363
165
Hanxiang Zhong. Non-alcoholic fatty liver disease: pathogenesis and models. American Journal of Translational Research 2024; 16(2): 387 doi: 10.62347/KMSA5983
166
Yunjie Liao, Nathan A. Davies, I. David L. Bogle. Computational Modeling of Fructose Metabolism and Development in NAFLD. Frontiers in Bioengineering and Biotechnology 2020; 8 doi: 10.3389/fbioe.2020.00762
167
Peter Hauff, Ulrich Gottwald, Matthias Ocker. Early to Phase II drugs currently under investigation for the treatment of liver fibrosis. Expert Opinion on Investigational Drugs 2015; 24(3): 309 doi: 10.1517/13543784.2015.997874
168
Silvia M. Ferolla. Obesity. 2016; : 159 doi: 10.1007/978-3-319-19821-7_13
169
Helena de Fatima Magliarelli, Mariette Matondo, Gergő Mészáros, Alexander Goginashvili, Eric Erbs, Zhirong Zhang, Michael Mihlan, Christian Wolfrum, Ruedi Aebersold, Izabela Sumara, Romeo Ricci. Liver ubiquitome uncovers nutrient-stress-mediated trafficking and secretion of complement C3. Cell Death & Disease 2016; 7(10): e2411 doi: 10.1038/cddis.2016.312
170
S. S. Loza-Medrano, L. A. Baiza-Gutman, L. Manuel-Apolinar, R. García-Macedo, L. Damasio-Santana, O. A. Martínez-Mar, M. C. Sánchez-Becerra, M. Cruz-López, M. A. Ibáñez-Hernández, M. Díaz-Flores. High fructose-containing drinking water-induced steatohepatitis in rats is prevented by the nicotinamide-mediated modulation of redox homeostasis and NADPH-producing enzymes. Molecular Biology Reports 2020; 47(1): 337 doi: 10.1007/s11033-019-05136-4
171
Dariush Mozaffarian. Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity. Circulation 2016; 133(2): 187 doi: 10.1161/CIRCULATIONAHA.115.018585
172
Elke Roeb, Ralf Weiskirchen. Fructose and Non-Alcoholic Steatohepatitis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.634344
173
Mohamed M. Elseweidy, Ahmed E. Elesawy, Mohammed S. Sobh, Gehad M. Elnagar. Ellagic acid ameliorates high fructose-induced hyperuricemia and non-alcoholic fatty liver in Wistar rats: Focusing on the role of C1q/tumor necrosis factor-related protein-3 and ATP citrate lyase. Life Sciences 2022; 305: 120751 doi: 10.1016/j.lfs.2022.120751
174
Xiangyu Guo, Xunzhe Yin, Zuojia Liu, Jin Wang. Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment. International Journal of Molecular Sciences 2022; 23(24): 15489 doi: 10.3390/ijms232415489
175
Mark F McCarty, James J DiNicolantonio. The cardiometabolic benefits of glycine: Is glycine an ‘antidote’ to dietary fructose?. Open Heart 2014; 1(1): e000103 doi: 10.1136/openhrt-2014-000103
176
Giacomo Germani, Marie Laryea, Laura Rubbia-Brandt, Hiroto Egawa, Patrizia Burra, John O'Grady, Kymberly D. Watt. Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation. Transplantation 2019; 103(1): 57 doi: 10.1097/TP.0000000000002485
177
Kasimu G. Ibrahim, Eliton Chivandi, Pilani Nkomozepi, Mashudu G. Matumba, Emmanuel Mukwevho, Kennedy H. Erlwanger. The long‐term protective effects of neonatal administration of curcumin against nonalcoholic steatohepatitis in high‐fructose‐fed adolescent rats. Physiological Reports 2019; 7(6): e14032 doi: 10.14814/phy2.14032
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345